» Articles » PMID: 35620020

Clinical Application Effects of Different Preoperative Blood Management Schemes in Older Patients with Delayed Intertrochanteric Fracture Surgery

Overview
Publisher Dove Medical Press
Specialty Geriatrics
Date 2022 May 27
PMID 35620020
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Research on preoperative blood management in older patients with delayed surgery for intertrochanteric fracture is scarce, especially regarding hematopoiesis and hemostasis. We assessed the effectiveness of optimized blood management programs in older patients undergoing delayed surgery for intertrochanteric fractures.

Methods: This retrospective study included 456 patients who underwent delayed surgery for intertrochanteric fractures. According to the optimized blood management plan, the patients were divided into four groups: group A was the control group; group B received 1 g of tranexamic acid (TXA) intravenously at admission; group C underwent sequential TXA treatment after admission until 1 day before surgery (1 g/day); and group D received iron supplements (200 mg/day) in addition to the treatment administered to group C, with or without recombinant human erythropoietin (rHuEPO; 40,000 IU). The primary outcomes were preoperative hidden blood loss (HBL), preoperative allogeneic blood transfusion (ABT) rate, hemoglobin (Hb) change, and actual Hb drop.

Results: The Hb reduction, calculated HBL, and hospitalization duration in groups C and D were significantly lower than those in groups A and B. The preoperative ABT rates in groups C and D were significantly lower than those in groups A and B, with no significant difference between groups C and D.

Discussion: The results of this study suggested that iron supplementation (with or without rHuEPO) combined with the sequential IV TXA scheme did not show a better clinical effect than the sequential IV TXA scheme in the management of patients undergoing delayed surgery for intertrochanteric fractures. Therefore, further evaluation is needed before recommending iron supplements and rHuEPO in older patients.

Citing Articles

Robot-assisted PFNA surgery improves clinical outcomes in the treatment of unstable femoral intertrochanteric fractures in elderly patients compared with traditional PFNA surgery.

Lu C, Wei X, Li L, Lan W, Wu P, Hu Q Sci Rep. 2025; 15(1):3836.

PMID: 39885317 PMC: 11782656. DOI: 10.1038/s41598-025-88229-4.


Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Management in Intertrochanteric Fractures: A Randomized Controlled Study.

Zhu C, Ji Z, Zhu J, Xu H, Li S, Liu C Med Sci Monit. 2024; 30:e944063.

PMID: 38875178 PMC: 11184985. DOI: 10.12659/MSM.944063.


Suboptimal Use of DOACs Post-Discharge for Geriatric Hip Fractures with Isolated Calf Deep Vein Thrombosis: Do Clinician Prescribing Preferences and Patient Compliance Alters Clinical Outcomes?.

Wang Z, Lu Y, Wang P, Fei C, Li S, Xue H Clin Interv Aging. 2023; 18:1423-1436.

PMID: 37663122 PMC: 10473050. DOI: 10.2147/CIA.S421422.

References
1.
Ma H, Wang H, Long X, Xu Z, Chen X, Li M . Early intravenous tranexamic acid intervention reduces post-traumatic hidden blood loss in elderly patients with intertrochanteric fracture: a randomized controlled trial. J Orthop Surg Res. 2021; 16(1):106. PMC: 7860029. DOI: 10.1186/s13018-020-02166-8. View

2.
Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y . Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32. DOI: 10.1016/S0140-6736(10)60835-5. View

3.
Kang Y, Liu J, Chen H, Ding W, Chen J, Zhao B . Enhanced recovery after surgery (ERAS) in elective intertrochanteric fracture patients result in reduced length of hospital stay (LOS) without compromising functional outcome. J Orthop Surg Res. 2019; 14(1):209. PMC: 6617739. DOI: 10.1186/s13018-019-1238-2. View

4.
Zhang S, Huang Q, Xu B, Ma J, Cao G, Pei F . Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: A large, single-center, retrospective study. Medicine (Baltimore). 2018; 97(1):e9429. PMC: 5943113. DOI: 10.1097/MD.0000000000009429. View

5.
Rosso F, Dettoni F, Bonasia D, Olivero F, Mattei L, Bruzzone M . Prognostic factors for mortality after hip fracture: Operation within 48 hours is mandatory. Injury. 2016; 47 Suppl 4:S91-S97. DOI: 10.1016/j.injury.2016.07.055. View